Beyond muscle destruction: A systematic review of rhabdomyolysis for clinical practice

Critical Care

Volumn 20, Issue 1, 2016, Pages

  Chavez, Luis O ^a   Leon, Monica ^b   Einav, Sharon ^c,d   Varon, Joseph ^e  

^a UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

^b UNIVERSIDAD POPULAR AUTÓNOMA DEL ESTADO DE PUEBLA   (Mexico)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e Foundation Surgical Hospital   (United States)

Author keywords

Acute kidney injury; Myoglobinuria; Myopathy; Rhabdomyolysis

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BICARBONATE; CALCIUM CHLORIDE; CREATINE KINASE; GLUCONATE CALCIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ILLICIT DRUG; INFUSION FLUID; MANNITOL; MYOGLOBIN; NARCOTIC ANALGESIC AGENT; PROPOFOL; RECREATIONAL DRUG;

ACIDOSIS; ACUTE KIDNEY FAILURE; ALCOHOL CONSUMPTION; CONNECTIVE TISSUE DISEASE; CONTINUOUS RENAL REPLACEMENT THERAPY; CREATINE KINASE BLOOD LEVEL; ELECTROLYTE DISTURBANCE; ENDOCRINE DISEASE; EXERCISE; FLUID THERAPY; HUMAN; HYPERVOLEMIA; HYPOCALCEMIA; IMMOBILIZATION; INFECTION; METABOLIC ACIDOSIS; MYALGIA; MYOPATHY; MYOSITIS; OPERATION DURATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; SEPSIS; SIDE EFFECT; SYSTEMATIC REVIEW; URINALYSIS; ACUTE KIDNEY INJURY; COMPLICATION; CRUSH TRAUMA; ISCHEMIA; MUSCLE DISEASE; PHYSIOLOGY; PROCEDURES; RISK FACTOR; SKELETAL MUSCLE;

ACUTE KIDNEY INJURY; CRUSH INJURIES; FLUID THERAPY; HUMANS; ISCHEMIA; MUSCLE, SKELETAL; MUSCULAR DISEASES; PHYSICAL EXERTION; RHABDOMYOLYSIS; RISK FACTORS;

EID: 84973594600     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-016-1314-5     Document Type: Review

References (64)

1. Huerta-Alardin AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis-an overview for clinicians. Crit Care. 2005;9(2):158-69.
2. Giannoglou GD, Chatzizisis YS, Misirli G. The syndrome of rhabdomyolysis: pathophysiology and diagnosis. Eur J Intern Med. 2007;19(2):90-100.
3. Bagley WH, Yang H, Shah KH. Rhabdomyolysis. Intern Emerg Med. 2007;2:210-8.
4. Landau ME, Kenney K, Deuster P, Campbell W. Exertional rhabdomyolysis: a clinical review with a focus on genetic influences. J Clin Neuromuscul Dis. 2012;13(3):122-36.
5. Chakravartty S, Sarma DR, Patel AG. Rhabdomyolysis in bariatric surgery: a systematic review. Obes Surg. 2013;23(8):1333-40.
6. Iwere RB, Hewitt J. Myopathy in older people receiving statin therapy: a systematic review and meta-analysis. Br J Clin Pharmacol. 2015;80(3):363-71.
7. Mehmet SS, Lameire N, Biesen WV, Vanholder R. Disaster nephrology: a new concept for an old problem. Clin Kidney J. 2015;8:300-9.
8. Bywaters E, Beall D. Crush injuries with impairment of renal function. Br Med J. 1941;1:427-32.
9. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361(1):62-72.
10. Chatzizisis YS, Misirli G, Hatzitolios AI, Giannoglou GD. The syndrome of rhabdomyolysis: complications and treatment. Eur J Intern Med. 2008;19(8):568-74.
11. Ron D, Taitelman U, Michaelson M, Bar-Joseph G, Bursztein S, Better OS. Prevention of acute renal failure in traumatic rhabdomyolysis. Arch Intern Med. 1984;144(2):277-80.
12. Sheng ZY. Medical support in the Tangshan earthquake: a review of the management of mass casualties and certain major injuries. J Trauma. 1987;27:1130-5.
13. Brown C, Rhee P, Chan L, Evans K, Demetriades D, Velmahos GC. Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference? J Trauma. 2004;56(6):1191-6.
14. Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore). 2005;84:377-85.
15. Sever MS, Vanholder R, Ashkenazi L, Becker G, Better O, Covic A, et al. Recommendation for the management of crush victims in mass disasters. Nephrol Dial Transplant. 2012;27 Suppl 1:i1-i67.
16. Mannix R, Tan ML, Wright R, Baskin M. Acute pediatric rhabdomyolysis: causes and rates of renal failure. Pediatrics. 2006;118:2119-25.
17. Lagandre S, Arnalsteen L, Vallet B, Robin E, Jany T, Onraed B, et al. Predictive factors for rhabdomyolysis after bariatric surgery. Obes Surg. 2006;16(10):1365-70.
18. de Oliveira LD, Diniz MT, de Fatima HS, Diniz M, Savassi-Rocha AL, Camargos ST, et al. Rhabdomyolysis after bariatric surgery by Roux-en-Y gastric bypass: a prospective study. Obes Surg. 2009;19(8):1102-7.
19. Linares LA, Golomb BA, Jaojoco JA, Sikand H, Phillips PS. The modern spectrum of rhabdomyolysis: drug toxicity revealed by creatine kinase screening. Curr Drug Saf. 2009;4(3):181-7.
20. Youssef T, Abd-Elaal L, Zakaria G, Haasheesh M. Bariatric surgery: rhabdomyolysis after open Roux-en-Y gastric bypass: a prospective study. Int J Surg. 2010;8(6):484-8.
21. Alpers JP, Jones Jr LK. Natural history of exertional rhabdomyolysis: a population-based analysis. Muscle Nerve. 2010;42(4):487-91.
22. Bache SE, Taggart I, Gilhooly C. Late-onset rhabdomyolysis in burn patients in the intensive care unit. Burns. 2011;37(7):1241-7.
23. Oshima Y. Characteristics of drugs-associated rhabdomyolysis: analysis of 8,610 cases reported to the U.S. Food and Drug administration. Intern Med. 2011;50(8):845-53.
24. Herraez Garcia J, Torracchi Carrasco AM, Antoli-Royo AC, et al. Rhabdomyolysis: a descriptive study of 449 patients. Med Clin (Barc). 2012;139(6):238-42.
25. El-Abdellati E, Eyselbergs M, Sirimsi H, Hoof VV, Wouters K, Verbrugghe W, et al. An observational study on rhabdomyolysis in the intensive care unit. Exploring its risk factors and main complication: acute kidney injury. Ann Intensive Care. 2013;3:8. doi: 10.1186/2110-5820-3-8.
26. Rodriguez E, Soler MJ, Rap O, Barrios C, Orfila MA, Pascual J. Risk factors for acute kidney injury in severe rhabdomyolysis. PLoS One. 2013;8(12):e82992.
27. Chen CY, Lin YR, Zhao LL, Yang WC, Chang YJ, Wu KH, et al. Clinical Spectrum of rhabdomyolysis presented to pediatric emergency department. BMC Pediatr. 2013;13:134.
28. Talving P, Karaanos E, Skiada D, Lam L, Teixeira P, Inaba K, et al. Relationship of creatine kinase elevation and acute kidney injury in pediatric trauma patients. J Trauma Acute Care Surg. 2013;74(3):912-6.
29. Grunau BE, Pourvali R, Wiens MO, Levin A, Li J, Grafstein E, et al. Characteritics and thirty-day outcomes of emergency department patients with elevated creatine kinase. Acad Emerg Med. 2014;21(6):631-6.
30. van Staa TP, Carr DF, O'Meara H, McCann G, Pirmohamed M. Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment. Br J Clin Pharmacol. 2014;78(3):649-59.
31. Pariser JJ, Pearce SM, Patel SG, Anderson BB, Packiam VT, Shalhav AL, et al. Rhabdomyolysis after major urologic surgery: epidemiology, risk factors, and outcomes. Urology. 2015;85(6):1328-32.
32. Antons KA, Williams CD, Baker SK, Phillips PS. Clinical perspectives of statin-induced rhabdomyolysis. Am J Med. 2006;119(5):400-9.
33. Harper CR, Jacobson TA. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Curr Opin Lipidol. 2007;18(4):401-8.
34. Iraj N, Saeed S, Mostafa H, Houshang S, Ali S, Farin RF, et al. Prophylactic fluid therapy in crushed victims of Bam earthquake. Am J Emerg Med. 2011;29:738-42.
35. Hohenegger M. Drug induced rhabdomyolysis. Curr Opin Pharmacol. 2012;12(3):335-9.
36. Zimmerman JL, Shen MC. Rhabdomyolysis. Chest. 2013;144(3):1058-65.
37. Torres PA, Helmestetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J. 2014;15(1):58-69.
38. Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJ, de Visser M. Rhabdomyolysis: review of the literature. Neuromuscul Disord. 2014;24(8):651-9.
39. Nance JR, Mammen AL. Diagnostic evaluation of rhabdomyolysis. Muscle Nerve. 2015;51(6):793-810.
40. Prendergast BD, George CF. Drug-induced rhabdomyolysis: mechanisms and management. Postgrad Med J. 1993;69:333-6.
41. Norata GD, Tibolla G, Catapano AL. Statins and skeletal muscles toxicity: from clinical trials to everyday practice. Pharmacol Res. 2014;88:107-13.
42. Boutaud O, Roberts 2nd LJ. Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failure. Free Radic Biol Med. 2011;51(5):1062-7.
43. Petejova N, Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care. 2014;18(3):224.
44. Shimada M, Dass B, Ejaz AA. Paradigm shift in the role of uric acid in acute kidney injury. Semin Nephrol. 2011;31(5):453-8.
45. Firwana BM, Hasan R, Hasan N, Alahdab F, Alnahhas I, Hasan S, et al. Tumor lysis syndrome: a systematic review of case series and case reports. Postgrad Med. 2012;124(2):92-101.
46. de Meijer AR, Fikkers BG, de Keijzer MH, van Engelen BG, Drenth JP. Serum creatine kinase as predictor of clinical course in rhabdomyolysis a 5-year intensive care survey. Intensive Care Med. 2003;29(7):1121-25.
47. Baeza-Trinidad R, Brea-Hernando A, Morera-Rodriguez S, Brito-Diaz Y, Sanchez-Hernandez S, El Bikri L, et al. Creatinine as predictor value of mortality and acute kidney injury in rhabdomyolysis. Intern Med J. 2015;45(11):1173-8.
48. Premru V, Kovač J, Ponikvar R. Use of myoglobin as a marker and predictor in myoglobinuric acute kidney injury. Ther Apher Dial. 2013;17:391-5.
49. Rodriguez-Capote K, Balion CM, Hill SA, Cleve R, Yang L, El Sharif A. Utility of urine myoglobin for the prediction of acute renal failure in patients with suspected rhabdomyolysis: a systematic review. Clin Chem. 2009;55(12):2190-7.
50. Thomas ME, Blaine C, Dawnay A, Devonald MA, Ftouh S, Laing C, et al. The definition of acute kidney injury and its use in practice. Kidney Int. 2015;87(1):62-73.
51. Talaie H, Emam-Hadi M, Panahandeh R, Hassanian-Moghaddam H, Abdollahi M. On the mechanisms underlying poisoning-induced rhabdomyolysis and acute renal failure. Toxicol Mech Methods. 2008;18:585-8.
52. Cervellin G, COmelli I, Lippi G. Rhabdomolysis: historical background, clinical, diagnostic and therapeutic features. Clin Chem Lab Med. 2010;48(6):749-56.
53. McMahon GM, Zeng X, Waikar SS. A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med. 2013;173(19):1821-8.
54. Scharman EJ, Troutman WG. Prevention of kidney injury following rhabdomyolysis: a systematic review. Ann Pharmacother. 2013;47(1):90-105.
55. Altintepe L, Guney I, Tonbul Z, Turk S, Mazi M, Agca E, et al. Early and intensive fluid replacement prevents acute renal failure in the crush cases associated with spontaneous collapse of an apartment in Konya. Ren Fail. 2007;29(6):737-41.
56. Cho YS, Lim H, Kim SH. Comparison of lactated Ringer's solution and 0.9 % saline in the treatment of rhabdomyoysis induced by doxylamine intoxication. Emerg Med J. 2007;24:276-80.
57. Zepeda-Orozco D, Ault BH, Jones DP. Factors associated with acute renal failure in children with rhabdomyolysis. Pedatr Nephrol. 2008;23:2281-4.
58. Sanadgol H, Najafi I, Rajabi Vahid M, Hossini M, Ghafari A. Fluid therapy in pediatric victims of the 2003 Bam, Iran earthquake. Prehosp Disaster Med. 2009;24:448-52.
59. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369:1243-51.
60. Zeng X, Zhang L, Wu T, Fu P. Continuous renal replacement therapy (CRRT) for rhabdomyolysis. Cochrane Database Syst Rev. 2014;6:CD008566.
61. Berend K, de Vries AP, Gans RO. Physiological approach to assessment of acid-base disturbances. N Engl J Med. 2015;372(2):195.
62. Bragadottir G, Redfors B, Ricksten SE. Mannitol increases renal blood flow and maintains filtration fraction and oxygenation in postoperative acute kidney injury: a prospective interventional study. Crit Care. 2012;16:R159.
63. Sorrentino SA, Kielstein JT, Lukasz A, Sorrentino JN, Gohrbandt B, Haller H, et al. High permeability dialysis membrane allows effective removal of myoglobin in acute kidney injury resulting from rhabdomyolysis. Crit Care Med. 2011;39:184-6.
64. Heyne N, Guthoff M, Krieger J, Haap M, Häring HU. High cut-off renal replacement therapy for removal of myoglobin in severe rhabdomyolysis and acute kidney injury: a case series. Nephron Clin Pract. 2012;121:159-64.